Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China

A Chinese biotechnology company, Shanghai Shiling Pharmaceutical, plans to complete clinical trials by 2028 for a weight-loss nasal spray that uses semaglutide, the same active ingredient as Danish drugmaker Novo Nordisk’s …

Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China Read More

Top 5 Trauma Healing Retreats for PTSD and CPTSD in Asia in 2025

Living with post-traumatic stress disorder (PTSD) or complex post-traumatic stress disorder (CPTSD) can feel like carrying an invisible weight that colours every aspect of life. The hypervigilance, intrusive memories, emotional …

Top 5 Trauma Healing Retreats for PTSD and CPTSD in Asia in 2025 Read More

Novo Nordisk and HSRI partner to raise Thailand’s clinical research standards

Novo Nordisk Thailand has signed an MoU with HSRI – and the Health Systems Research Institute  – to strengthen Thailand’s clinical research infrastructure and foster healthcare innovation. The agreement, witnessed …

Novo Nordisk and HSRI partner to raise Thailand’s clinical research standards Read More

Thammasat University Hospital and Novo Nordisk Thailand join forces to fight obesity and diabetes

Thammasat University Hospital and Novo Nordisk Pharma (Thailand) Ltd. have launched a new collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity, …

Thammasat University Hospital and Novo Nordisk Thailand join forces to fight obesity and diabetes Read More
Emil Akander, Vice President and Head of Region for the Asia-Pacific - Business Sweden

Bavarian Nordic secures EU approval for first chikungunya vaccine

Bavarian Nordic, a Danish biotechnology company specializing in vaccine development, was on 28 February 2025 granted marketing authorization in the EU for their chikungunya vaccine, VIMKUNYA®. Chikungunya is a mosquito-borne …

Bavarian Nordic secures EU approval for first chikungunya vaccine Read More

Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute

Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, Huang Zhenhua, alleging KBP Biosciences misrepresented the effectiveness of an experimental hypertension drug, …

Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute Read More

Danish government considers medication imports from Asia, including Thailand and China

The Danish government’s controversial proposal to allow the import of medication from several Asian countries, such as Thailand, India, and China, has stirred a significant debate that reaches beyond Danish …

Danish government considers medication imports from Asia, including Thailand and China Read More

Air pollution linked to infertility risk for Danish men, China in similar concerns

A new study from Roskilde University has uncovered a significant connection between air pollution and increased infertility risk among Danish men. According to the research, for every 5 micrograms per …

Air pollution linked to infertility risk for Danish men, China in similar concerns Read More

Siriraj Hospital and Novo Nordisk partner on chronic diseases research and development

Siriraj Hospital, part of Mahidol University’s Faculty of Medicine, has signed a Memorandum of Understanding (MOU) with Novo Nordisk Pharma (Thailand) Co., Ltd. This agreement aims to advance research and …

Siriraj Hospital and Novo Nordisk partner on chronic diseases research and development Read More